Rishi Miriyala Anantharaj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rishi Miriyala Anantharaj has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Abbass A. Alhassani
Department of Surgery, College of Medicine, University of Basrah, Basrah, Iraq
1 shared publication Ahkash Thavarajasingam
Imperial Brain & Spine Initiative, Imperial College London, London, United Kingdom
1 shared publicationAhmed Salih
Imperial Brain & Spine Initiative, Imperial College London, London, United Kingdom
1 shared publication- Ali Abutiheen
College of Medicine, Kerbala University, Karbala, Iraq
1 shared publication Ali R. Hashim
Department of Internal Medicine, College of Medicine, University of Basrah, Basrah, Iraq
1 shared publicationAmeen AlAlwany
College of Medicine, University of Baghdad, Baghdad, Iraq
1 shared publication
Latest Publications
- Open Access
- 16 August 2026
- Published by Elsevier in IJID Regions
- Vol. 21, 100976
The burden of antimicrobial resistance in Iraq: an analysis from 2021
- 16 August 2026
- Published by Elsevier in IJID Regions
- Vol. 21, 100976
Open AccessThe burden of antimicrobial resistance in Iraq: an analysis from 2021
- Open Access
- 19 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Implementing Blockchain Technology for Efficient Healthcare: A Systematic Review (Preprint)
BACKGROUND Background: Blockchain (distributed ledger technology) is proposed to address persistent healthcare problems - data integrity, security, auditability and interoperability - yet most activity remains at pilot scale with few national deployments. This review synthesises current healthcare uses of blockchain and the barriers to scaling. OBJECTIVE The aims and objectives of this study are as follows: To identify and discuss the key use cases of blockchain in healthcare currently To identify and discuss the limitations of blockchain implementation into healthcare METHODS Following Cochrane guidance and PRISMA, we searched PubMed, MEDLINE, Embase, Scopus, SAGE, Cochrane Library and Google Scholar. English-language records from 2008 onward mentioning blockchain/DLT were eligible. Two reviewers independently screened abstracts and full texts; disagreements were resolved by a third. Data were extracted in Covidence and studies thematically grouped. Primary studies proposing solutions underwent a quality assessment tool for risk of bias. RESULTS Of 2,826 records screened, 261 full texts were assessed; 17 primary studies and 122 reviews/commentaries were included. Four dominant use cases emerged: clinical trials, pharmaceutical supply chains, telehealth and electronic health records. Evidence is promising but heterogeneous; quality assessments were inconsistent. National-level implementations were rare but not unseen. Three recurring barriers to scale were identified and mapped with a Sankey diagram to aid visualisation: regulatory friction (e.g., GDPR erasure vs ledger immutability, accountability in decentralised systems), infrastructure constraints, and misalignment between developers and regulators (performance vs governance needs). CONCLUSIONS Blockchain shows clear potential across four healthcare domains, but system-wide adoption lags. Progress will require hybrid architectures, early co-design with regulators, and common technical/legal standards, alongside more rigorous, outcomes-focused evaluations beyond pilot settings.
- 19 January 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImplementing Blockchain Technology for Efficient Healthcare: A Systematic Review (Preprint)
BACKGROUND Background: Blockchain (distributed ledger technology) is proposed to address persistent healthcare problems - data integrity, security, auditability and interoperability - yet most activity remains at pilot scale with few national deployments. This review synthesises current healthcare uses of blockchain and the barriers to scaling. OBJECTIVE The aims and objectives of this study are as follows: To identify and discuss the key use cases of blockchain in healthcare currently To identify and discuss the limitations of blockchain implementation into healthcare METHODS Following Cochrane guidance and PRISMA, we searched PubMed, MEDLINE, Embase, Scopus, SAGE, Cochrane Library and Google Scholar. English-language records from 2008 onward mentioning blockchain/DLT were eligible. Two reviewers independently screened abstracts and full texts; disagreements were resolved by a third. Data were extracted in Covidence and studies thematically grouped. Primary studies proposing solutions underwent a quality assessment tool for risk of bias. RESULTS Of 2,826 records screened, 261 full texts were assessed; 17 primary studies and 122 reviews/commentaries were included. Four dominant use cases emerged: clinical trials, pharmaceutical supply chains, telehealth and electronic health records. Evidence is promising but heterogeneous; quality assessments were inconsistent. National-level implementations were rare but not unseen. Three recurring barriers to scale were identified and mapped with a Sankey diagram to aid visualisation: regulatory friction (e.g., GDPR erasure vs ledger immutability, accountability in decentralised systems), infrastructure constraints, and misalignment between developers and regulators (performance vs governance needs). CONCLUSIONS Blockchain shows clear potential across four healthcare domains, but system-wide adoption lags. Progress will require hybrid architectures, early co-design with regulators, and common technical/legal standards, alongside more rigorous, outcomes-focused evaluations beyond pilot settings.
- Open Access
- 5 February 2025
- Published by Elsevier in Brain and Spine
- Vol. 5, 104208
The diagnostic and prognostic capability of artificial intelligence in spinal cord injury: A systematic review
- 5 February 2025
- Published by Elsevier in Brain and Spine
- Vol. 5, 104208
Open AccessThe diagnostic and prognostic capability of artificial intelligence in spinal cord injury: A systematic review